The Journal of Immunology, Vol 143, Issue 7 2112-2119, Copyright © 1989 by American Association of Immunologists

ARTICLES

Characterization of anti-CD8-resistant cytolytic T lymphocytes induced by multivalent cross-linking of CD8 on precursor cells

SA McCarthy, E Kaldjian and A Singer
Experimental Immunology Branch, National Cancer Institute, Bethesda, MD 20892.

The lytic activity of most CD8+ MHC class I allospecific CTL generated in vitro can be inhibited by anti-CD8 antibodies. Such inhibition has led to hypotheses that CD8/class I interactions normally contribute to the triggering of CTL with low or moderate avidity Ag-specific TCR by providing those CTL with auxiliary binding avidity. However, CD8 has also been proposed to play an active signaling role in T cell activation. We have recently reported that multivalent cross-linking of CD8 on CTL precursors in MLC does appear to mediate activation signals, and induces the generation of CD8+ MHC class I allospecific CTL whose lytic activity cannot be blocked by anti-CD8 antibodies. In our present study, we have further characterized such anti-CD8 uninhibitable effector cells. These CTL are resistant to blocking of their lytic function by anti-Lyt-3 mAb as well as anti-Lyt-2 mAb, but remain sensitive to blocking by anti-LFA-1 mAb, indicating that they do use non-CD8 cell adhesion molecules during target cell recognition and lysis. As a consequence of mAb-induced multivalent CD8 cross-linking during their generation, anti-CD8 uninhibitable CTL significantly reduce their cell surface expression of CD8, which permits their identification and facilitates their purification from heterogeneous MLC populations. Such anti-CD8 uninhibitable effector cells can be maintained as stable CTL lines, in the absence of anti-CD8 mAb after the initial induction period. The in vitro generation of anti-CD8 uninhibitable CTL, which may be highly enriched for cells bearing high affinity TCR, could represent a new experimental approach to studies of TCR gene usage and repertoire, as well as a potentially important strategy for the deliberate generation of high affinity effector cells for adoptive immunotherapy.

This article has been cited by other articles:

				S. Tian, R. Maile, E. J. Collins, and J. A. Frelinger CD8+ T Cell Activation Is Governed by TCR-Peptide/MHC Affinity, Not Dissociation Rate J. Immunol., September 1, 2007; 179(5): 2952 - 2960. [Abstract] [Full Text] [PDF]

				E. S. N. Lamouse-Smith, D. S. Dougall, and S. A. McCarthy Cytokine Requirements for Production of a Novel Anti-CD8-Resistant CTL Population J. Immunol., October 15, 1999; 163(8): 4160 - 4167. [Abstract] [Full Text] [PDF]

				P. A. Smith and T. A. Potter Alloreactive T Cells That Do Not Require TCR and CD8 Coengagement Are Present in Naive Mice and Contribute to Graft Rejection J. Immunol., June 1, 1998; 160(11): 5382 - 5389. [Abstract] [Full Text] [PDF]

				S. A. McCarthy, M. S. Mainwaring, D. S. Dougall, and E. S. Lamouse-Smith Activation Requirements, Lytic Mechanism, and Development of a Novel Anti-CD8-Resistant CTL Population J. Immunol., March 15, 1998; 160(6): 2715 - 2724. [Abstract] [Full Text] [PDF]